Indomethacin 75 mg (Sustained Release) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Indomethacin 75 mg (Sustained Release) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Non-Selective NSAID (Strong)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Indomethacin 75 mg (Sustained Release) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Indomethacin 75 mg (Sustained Release) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Indomethacin 75 mg (Sustained Release) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Indomethacin 75 mg (Sustained Release) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Acute gouty arthritis
- Ankylosing spondylitis
- Rheumatoid arthritis (acute flares)
- Acute musculoskeletal inflammation
Mechanism of Action
Indomethacin is a potent non-selective COX-1 and COX-2 inhibitor that suppresses prostaglandin synthesis. Stronger anti-inflammatory effect than newer NSAIDs but higher CNS penetration causing headache.
Dosage & Administration
- Adults: 75 mg SR once or twice daily after food.
Side Effects
- Headache (frequent), dizziness, GI upset, peptic ulcer, fluid retention, transaminase elevation.
Contraindications
- Active peptic ulcer, severe heart failure, third trimester pregnancy, severe renal/hepatic impairment, aspirin-sensitive asthma.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Indomethacin 75 mg (Sustained Release) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Indomethacin 75 mg (Sustained Release) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Indomethacin 75 mg (Sustained Release) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Indomethacin 75 mg (Sustained Release) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Indomethacin 75 mg (Sustained Release) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Indomethacin 75 mg (Sustained Release) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Indomethacin 75 mg (Sustained Release) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Indomethacin 75 mg (Sustained Release) Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Indomethacin 75 mg (Sustained Release) Tablet?
MRPs range from ₹995 to ₹995 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Indomethacin 75 mg (Sustained Release) Tablet?